Diabetes Vaccine Is Currently In A Phase II Trial

The first Seattle-Sweden Childhood Diabetes Awareness Day in Seattle, Washington is being organized by Professor Åke Lernmark who works at the University of Washington and the Consulate General of Sweden in L.A., on 1st April. The symposium will feature presentations by researchers from Sweden and Seattle. Speakers include Professor Carl David Agardh of Malmö’s University Hospital. Diamyd Medical, one of the key sponsors, will also give a presentation of its diabetes vaccine that is currently in a Phase II trial.

For reasons unknown to researchers, the incidence rate of Type 1 diabetes in Seattle is on par with that of Sweden, which has the second-highest rate in the world of young people suffering from diabetes. As a result, much of the research for Diamyd Medical’s lead diabetes vaccine has been carried out at US universities in Seattle, San Francisco, and Los Angeles, as well as at Swedish universities in Lund, Uppsala, Stockholm, Umea and Linkoping.

Link [biotech.idg.se/ArticlePages/200603/30/20060330091711_BIO/20060330091711_BIO.dbp.asp]

Filed under Diabetes | Comment Below


Leave a Reply

Protected by Comment Guard Pro